Engineered nanoparticles sensitize gliomas to radiotherapy
Gliomas are a major cause of cancer-related deaths in younger adults. About 7,000 patients harbor a common genetic mutation that affects the enzyme isocitrate dehydrogenase 1. This mutated enzyme, called mIDH1, can produce a molecule that can reprogram both the tumor cells and th
Gliomas are a major cause of cancer-related deaths in younger adults. About 7,000 patients harbor a common genetic mutation that affects the enzyme isocitrate dehydrogenase 1. This mutated enzyme, called mIDH1, can produce a molecule that can reprogram both the tumor cells and th This story matters for Science & Discovery readers tracking mech. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. MechNews curates and briefs the science & discovery stories that matter. Our editorial policy →